Insider filing · HOWL
Werewolf Therapeutics, Inc.
HOWL · Healthcare · 14 filings in 24 months
ticker →
UBS Oncology Impact Fund L.P. sold $446K of Werewolf Therapeutics (HOWL)
Executed Oct 27 2025, disclosed Oct 29 2025, 2 days later.
Value, as filed
$446K
276,017 sh across 3 lots
Executed
Oct 27 2025
the trade date, as filed
Disclosed
Oct 29 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
UP
UBS Oncology Impact Fund L.P.
10% owner
profile →
UBS Oncology Impact Fund L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Werewolf Therapeutics, Inc. (HOWL). The largest single filing was $446K of HOWL (276,017 sh across 3 lots, as filed), executed Oct 27 2025.
The name
HOWLHealthcare · Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's imm…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→